In prostate cancer, prostatic specific antigen (PSA) is a useful prostate cancer marker that is complexed with AACT, as shown in Fig. 2, and the PSA-AACT levels were increased in moderately differentiated prostate cancer tissues [46]. This evidence concerns the gene KLK3 and prostate cancer.